Infliximab - "How to test Therapeutic Drug Monitoring (TDM) of Infliximab with AFIAS platform"

TDM is to optimize anti-TNF biologic treatment in patients with Inflammatory bowel disease (IBD) and Rheumatoid arthritis (RA). AFIAS Infliximab test can measure Infliximab level with a small amount of human serum, plasma, and whole blood in 10 mins.
It provides information regarding the patients’ response to the treatment of infliximab. The test result can help with clinical decision making.
See more: bit.ly/3GZzReX